Table 1 Clinicopathological features of 161 patients for profiling cancer gene mutations

From: Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma

Factors

No. of patients

%

Gender

 Male

140

87.0

 Female

21

13.0

Age (years)

 ≤65

128

79.5

 >65

33

20.5

Mean, median (range)

60.2, 61.0 (43–79)

 

Body mass index (kg/m2)

  

 <18.5

30

18.6

 18.5–25

119

73.9

 >25

11

6.8

Missing

1

0.6

Mean, median (range)

21.0, 20.8 (15.4–29.3)

 

Smoking history

 No

36

22.4

 Yes

124

77.0

 Missing

1

0.6

Alcohol intake

 No

43

26.7

 Yes

117

72.7

 Missing

1

0.6

Family history

 No

112

69.6

 Yes

48

29.8

 Missing

1

0.6

Tumor location

 Upper

13

8.1

 Middle

96

59.6

 Lower

52

32.3

Grade

 Well

2

1.2

 Moderate

118

73.3

 Poor

37

23.0

 Missing

4

2.5

Clinical stage

 I

1

0.6

 II

4

2.5

 IIIa

91

56.5

 IIIb

47

29.2

 IIIc

18

11.2